Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial

Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record describes a completed Phase 4 study of mepolizumab for Indian adults with severe eosinophilic asthma, including its treatment plan, participant criteria, and measured outcomes. It also provides study results resources and information about sharing participant data.
    Difference
    58%
    Check dated 2026-11-08T04:54:18.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T02:03:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice was added above the study record stating that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:57:42.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:47:02.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T02:13:08.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    No additions or deletions were reported for this page. The page currently displays a 403 Forbidden error, indicating access is restricted.
    Difference
    0.2%
    Check dated 2026-09-27T02:10:19.000Z thumbnail image

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.